Stock listing
Surrozen, Inc.
Selected listing: SRZN · NASDAQ · USD · US
Surrozen, Inc. (NASDAQ:SRZN), Health Technology. Latest release Oct 2, 2026: Surrozen Announces FDA Clearance of IND Application for SZN-8141…
- Ticker
- NASDAQ:SRZN
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Surrozen, Inc.
Surrozen, Inc. is a public company traded under the ticker SRZN in the American market. Surrozen focuses on developing innovative therapies to address unmet medical needs.
Latest news from Surrozen, Inc.
Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
October 1, 2026
Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
October 2, 2026
Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
September 8, 2026
Surrozen : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)
August 6, 2026
Surrozen Reports Second Quarter 2026 Financial Results and Provides Business Update
August 6, 2026
Events
Replays
Surrozen, Inc. (SRZN) Q4 2022 Earnings Call
Thu, Mar 23, 2023 · 04:30 PM ET
Watch